Physician profile
Dan Siapco
NPI 1881631273
$970.87
in general payments reported to CMS, 2019-2025
7 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $148 · 2021: $118 · 2022: $104 · 2023: $64.81 · 2024: $63.23 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $402.90 | 2019-2023 | Tecnis Iol |
| Alcon Vision LLC | $220.07 | 2019-2025 | Argos, Clareon |
| Rayner Intraocular Lenses Limited | $167.51 | 2024-2025 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Glaukos Corporation | $113.99 | 2019-2025 | Idosetr, Istent |
| Sight Sciences, INC. | $30.33 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Harrow Eye, LLC | $16.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Siapco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.